Machine Learning

ActiveCampaign is shaking up the martech world with a 30-day results guarantee, promising instant AI-driven outcomes or a full refund.

A new biotech emerges with massive funding and a next-gen 'shuttle' to deliver safer, more effective Alzheimer's therapies directly to the brain.

Auddia Inc. announces a merger with its CEO's holdings, creating a new $250M entity, McCarthy Finney, and leaving current shareholders with a 20% stake.

Investment in Canadian fintech moderated to $2.4B in 2025, but a closer look reveals a healthy shift toward strategic AI and digital asset deals.

As agentic AI adoption accelerates, Cloud Range's new platform offers a secure environment for organizations to test and validate AI models before deployment.

A Qatar-based cleantech firm plans to solve water scarcity by pulling it from the sky, and a £20M investment is set to fuel its global ambitions.

A new report reveals retail traders are abandoning anonymous forums for platforms with audited data, professionalizing the meme stock era for good.

A breakthrough cell line shows a two-fold increase in viral vector quality, a key step in making gene therapies more effective, safer, and accessible.

comforte AG and ITSS Global launch a joint solution using tokenization to help banks secure PII and enable AI while ensuring compliance.

The specialty minerals giant reports solid Q4 earnings while announcing a major strategic shift away from industrial ventures to focus on high-growth areas.

Positive early trial data for ZP9830 shows promise for a new class of targeted autoimmune therapies, marking a strategic pivot for Zealand Pharma.

Photocure reports robust Q4 earnings and a strong 2026 forecast, while pivoting to an AI-driven future for bladder cancer diagnostics and global expansion.

Quantitative giant Voloridge is adding up to 200 high-tech jobs in Jupiter, anchoring a waterfront revival and solidifying the area's 'Silicon Shores' status.

A new report reveals how AI search, data privacy, and patient trust are forcing medical practices to adopt a radically new playbook to attract patients.

With an 11% dividend hike and 22 years of growth, ADI proves its stability while investing heavily in the future of AI, automotive, and healthcare.

Data storage firm Quantum posts a surprise Q3 revenue beat and improved profits, but can its AI strategy and debt overhaul secure a long-term future?

A groundbreaking collaboration is turning discarded biopsy material into a powerful tool for AI-driven cancer diagnostics, promising a new era of proactive care.

As Jazz Pharmaceuticals preps for key investor talks, all eyes are on its blockbuster pipeline, revenue growth, and strategy to fend off competition.

Facing massive revenue declines and a shrinking coach network due to GLP-1 drugs, Medifast bets its future on a risky pivot from weight loss to metabolic health.

A landmark partnership in Greensboro creates a first-of-its-kind pathway for students to gain tech skills and college credit, tackling the state's talent gap.